The RSH/Smith-Lemli-Opitz syndrome (RSH/SLOS) is an autosomal recessive malformation syndrome associated with increased levels of 7-dehydrocholesterol (7-DHC) and a defect of cholesterol biosynthesis at the level of 3B-hydroxy-steroid-A'reductase (7-DHC reductase). Because rats exposed to inhibitors
Smith-Lemli-Opitz syndrome in trisomy 13: How does the mix work?
✍ Scribed by Fowzan S. Alkuraya; Jonathan Picker; Mira B. Irons; Virginia E. Kimonis
- Book ID
- 101705607
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 159 KB
- Volume
- 73
- Category
- Article
- ISSN
- 1542-0752
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
BACKGROUND
Trisomy 13 and Smith‐Lemli‐Opitz syndrome (SLOS) are both well‐recognized multiple congenital anomaly/mental retardation syndromes.
CASE
In this report we describe a male newborn with trisomy 13 who also has features of SLOS, such as 2/3 toe syndactyly and a shawl‐like scrotum. Biochemical analysis was consistent with SLOS, and limited molecular analysis revealed 1 mutation in the DHCR7 gene.
CONCLUSIONS
The challenges in establishing the diagnosis of SLOS in this patient are presented and the unique coexistence of the 2 major malformation syndromes is discussed. Given the overlapping phenotype of the 2 syndromes, our report should encourage further research on cholesterol biosynthesis in patients with trisomy 13. Birth Defects Research (Part A), 2005. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES